Amundi Asset Management US’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-19,828
Closed -$83K 1708
2018
Q3
$83K Hold
19,828
﹤0.01% 1490
2018
Q2
$77K Buy
19,828
+2,797
+16% +$10.9K ﹤0.01% 1486
2018
Q1
$108K Buy
+17,031
New +$108K ﹤0.01% 1402